Re: ZHCLF up 290% to $0.16...question
in response to
by
posted on
Dec 11, 2020 04:56PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Koo,
Nothing in your reply proves that ZHCLF is the US version of ZENI-P. There is no hard evidence of that. If you have some, please show me.